Billable / Specific Code
ICD-10-CM C7A.098 is the diagnosis code for Malignant carcinoid tumors of other sites. This code falls under the section "Malignant neuroendocrine tumors" within Chapter 2 — Neoplasms (C00-D49). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Always refer to the official ICD-10-CM Tabular List for complete coding guidelines. Ensure documentation supports the specificity of the code selected. When in doubt, consult a certified medical coder or the latest CMS guidelines.
Understanding where C7A.098 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, C7A.098 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
C7A.098 is the ICD-10-CM diagnosis code for "Malignant carcinoid tumors of other sites". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of C7A.098 is C7A.09 ("Malignant carcinoid tumors of other sites"). C7A.098 provides a more specific classification within this category.
C7A.098 is located in Section C7A — "Malignant neuroendocrine tumors" within Chapter 2 of the ICD-10-CM Tabular List.
Use C7A.098 when the patients documented diagnosis matches "Malignant carcinoid tumors of other sites" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Malignant carcinoid tumors of other sites is C7A.098.
Yes, C7A.098 can be used as a primary diagnosis code since it is billable and specific.
C7A.098 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, C7A.098 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.